90 related articles for article (PubMed ID: 23267989)
21. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers.
Komori T; Doki Y; Kabuto T; Ishikawa O; Hiratsuka M; Sasaki Y; Ohigashi H; Murata K; Yamada T; Miyashiro I; Mano M; Ishiguro S; Imaoka S
J Surg Oncol; 2003 Jan; 82(1):19-27. PubMed ID: 12501165
[TBL] [Abstract][Full Text] [Related]
23. Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
Liu J; Hu Y; Xie X; Fu J
Ann Thorac Surg; 2012 Feb; 93(2):423-7. PubMed ID: 22178587
[TBL] [Abstract][Full Text] [Related]
24. [Characteristics of lymph node metastasis in thoracic esophageal carcinoma].
Li JD; Wang WG; Xu JL; Gao ZR; Shao LF
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3197-200. PubMed ID: 17313786
[TBL] [Abstract][Full Text] [Related]
25. Intraoperative pathological investigation of recurrent nerve nodal metastasis can guide the decision whether to perform cervical lymph node dissection in thoracic esophageal cancer.
Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Komatsu S; Yamagishi H
Oncol Rep; 2006 Nov; 16(5):1061-6. PubMed ID: 17016593
[TBL] [Abstract][Full Text] [Related]
26. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
[TBL] [Abstract][Full Text] [Related]
28. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
31. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
33. [Influence of the number of lymph node metastasis on survival and significance of postoperative radiotherapy for esophageal carcinoma].
Xiao ZF; Yang ZY; Wang LH; Zhang HX; Feng QF; Chen DF; Zhou ZM; Zhang DC; Sun KL; Cheng GY; He J
Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):112-5. PubMed ID: 15059333
[TBL] [Abstract][Full Text] [Related]
34. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
35. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
36. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
37. [Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy].
Hiraki M; Yunotani S; Noguchi R; Shinozaki Y; Tani H; Sakai M; Ishimitsu T; Tabuchi M
Gan To Kagaku Ryoho; 2005 Feb; 32(2):219-21. PubMed ID: 15751636
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation of low-dose cisplatin and 5-fluorouracil as adjuvant chemoradiotherapy for advanced squamous cell carcinoma of the esophagus.
Shimizu K; Hihara J; Yoshida K; Toge T
Hiroshima J Med Sci; 2005 Sep; 54(3):67-71. PubMed ID: 16180698
[TBL] [Abstract][Full Text] [Related]
40. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]